<img alt="" src="https://secure.wake4tidy.com/244317.png" style="display:none;">

Vironova at NEUBIAS conference

Vironova is represented this week by Ida-Maria Sintorn at the NEUBIAS symposium in Luxembourg. The 3rd Annual Conference of NEUBIAS, gathers the whole BioImage Analysis Community into a fully-packed event with aspects of bioimage analysis in life...


MiniTEM™ for quality analysis of phage preparations

  Poster presentation at the Phage Future Congress 2019 On January 29th Vironova will be attending The Phage Futures Congress in Washington D.C. to follow key industry trends together with peers from biotech companies and academia. Experts from...


Podcast viral vector manufacturing

Transmission electron microscopy in analysing viral and non-viral vectors for gene therapy is the subject of our latest podcast and blog article by Vanessa Carvalho, Senior scientist at Vironova AB. Our customers working with gene therapy and AAV...


Artificial Intelligence Leadership and Lifelong Learning

Vironova's COO, Maria Homman was recently involved in staging a seminar and debate at IVA (The Royal Swedish Academy of Engineering Sciences) as part of the IFG Leadership Development program. The subject translates to "AI the new leader in a...


Lausanne ESGCT conference

Successful presence at cell and gene therapy meet Last week Vironova attended the 26th annual meeting of the European Society of Gene and Cell Therapy  (ESGCT)  in Lausanne, Switzerland.


Presentation computer vision Munich

A conference paper was presented by Vironova’s collaborator Elisabeth Wetzer at the Workshop on BioImage Computing, European Conference on Computer Vision (ECCV), 8-14 September in Munich.


Maria studiebesök IVA Finland Estonia

Helping to sharpen Sweden’s edge in advanced technology development Maria Homman, COO of Vironova has been out travelling with the IFG leadership development program of IVA (the royal Swedish Academy of Engineering Sciences). The program is based on...


Vironova at the VLPNPV conference

A successful meeting at VLPNPV 2018 in Bern, Switzerland Last week, 25-27 September, Vironova attended the Virus-Like Particle & Nano-Particle Vaccines conference in Bern, Switzerland.  We succeeded in generating even more awareness of the Vironova...


Vironova in panel discussion on cell and gene therapy

This week Vironova is participating in a panel discussion at the Cell and Gene Therapy Bioprocessing and Commercialization conference in Boston, represented by Nina Forsberg, Marketing Director.


New ASTM standard approved

Vironova scientists continue to influence the field - new standard approved In the spring of 2017 Vironova, being identified as leading experts in the characterization of liposomes, was invited by the FDA to participate in developing a standard for...